Abstract
Background: This study aimed to see if rifampicin susceptibility can be determined on repeat sampling in pulmonary tuberculosis with a trace call on the first GeneXpert Ultra report. Methods: This retrospective cohort study included adults with a GeneXpert Ultra trace call in the first respiratory sample from January 2021 to June 2024. Results: Of the 27 patients with repeat sampling done after the initial trace call, rifampicin susceptibility could be determined in 37% (n=10) of patients. Conclusions: Repeating GeneXpert Ultra testing in patients with an initial trace call is valuable for determining rifampicin susceptibility.
| Original language | English |
|---|---|
| Pages (from-to) | 626-628 |
| Number of pages | 3 |
| Journal | Transactions of the Royal Society of Tropical Medicine and Hygiene |
| Volume | 119 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 01-06-2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Parasitology
- Public Health, Environmental and Occupational Health
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Impact of repeat testing in tuberculosis patients with a trace call on Xpert MTB/RIF Ultra: a retrospective cohort study'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver